Advanced search
Publication Cover
Leukemia & Lymphoma Volume 43, 2002 - Issue 12
Submit an article Journal homepage
32
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Quantitative Monitoring of BCR / ABL Transcript During STI-571 Therapy

Catherine J. Wu Center for Hematologic Oncology and Department of Biostatistics, Dana-Farber Cancer Institute, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA
,
Donna Neuberg Center for Hematologic Oncology and Department of Biostatistics, Dana-Farber Cancer Institute, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA
,
Antoinette Chillemi Center for Hematologic Oncology and Department of Biostatistics, Dana-Farber Cancer Institute, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA
,
Stephen McLaughlin Center for Hematologic Oncology and Department of Biostatistics, Dana-Farber Cancer Institute, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA
,
Ephraim P. Hochberg Center for Hematologic Oncology and Department of Biostatistics, Dana-Farber Cancer Institute, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA
,
Ilene Galinsky Center for Hematologic Oncology and Department of Biostatistics, Dana-Farber Cancer Institute, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA
,
Daniel DeAngelo Center for Hematologic Oncology and Department of Biostatistics, Dana-Farber Cancer Institute, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA
,
Robert J. Soiffer Center for Hematologic Oncology and Department of Biostatistics, Dana-Farber Cancer Institute, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA
,
Edwin P. Alyea Center for Hematologic Oncology and Department of Biostatistics, Dana-Farber Cancer Institute, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA
,
Renaud Capdeville Center for Hematologic Oncology and Department of Biostatistics, Dana-Farber Cancer Institute, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA
,
Richard M. Stone Center for Hematologic Oncology and Department of Biostatistics, Dana-Farber Cancer Institute, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA
&
Jerome Ritz Center for Hematologic Oncology and Department of Biostatistics, Dana-Farber Cancer Institute, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA
 show all
Pages 2281-2289 | Published online: 01 Jul 2009

  • Melo, J.V. (1996) "The diversity of BCR/ABL fusion proteins and their relationship to leukemia phenotype". Blood 88, 2375-2384.
  • Deininger, M.W., Goldman, J.M. and Melo, J.V. (2000) "The molecular biology of chronic myeloid leukemia", Blood 96, 3343-3356.
  • Daley, G.Q., Van Enen, R.A. and Baltimore, D. (1990) "Induction of chronic myelogenous leukemia in mice by the P210ber/abl gene of the Philadelphia chromosome", Science 247, 824-830.
  • Laurent, E., Talpaz, M., Kantarjian, H. and Kurzrock, R. (2001) "The BCR gene and Philadelphia chromosome-positive leukemogenesis". Cancer Res, 61. 2343-2355.
  • Buchdunger, E., Zimmermann, J., Mett, H., Meyer, T., Muller, M., Drucker, B.J. and Lydon, N.B. (1996) "Inhibition of the Abl proteintyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative", Cancer Res. 56, 100-104.
  • Druker. B.J. Tamura, S., Buchdunger, E., Ohno, S., Segal, G.M., Fanning, S., Zimmermann, J., and Lydon, N.B. (1996) "Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of BerAbl positive cells", Nat. Med. 2, 561-566.
  • Deininger, M.W., Goldman, J.M., Lydon, N, and Melo, J.V. (1997) "The Tyrosine kinase inhibitor CGP57148B selectively inhibits the growth of BCR-ABL-postive cells", Blood 90, 3691-3698.
  • Druker, B.I., Sawyers, C.L., Kantarjian, H., Resta, D.J., Reese, S.F., Ford, J.M., Capdeville, R. and Talpaz, M. (2001) "Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chromic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome", N. Engl. J. Med. 344, 1038-1042.
  • Druker, B.J., Talpaz, M., Resta. D.J., Peng, B., Buchdunger, E., Ford, J.M., Lydon. N.B., Kantarjin, H., Capdeville, R., Ohno-Jones, S. and Sawyers, C.L. (2001) "Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chromic myeloid leukemia". N. Engl. J. Med 344, 1031-1037.
  • Amarante-Mendes, G.P., Naekyung Kim, C. Liu. L., Huang, Y., Parkins. C.L., Green. U.K. and Bhalla. K, (1998) "Ber-Abl exerts its antiapoptotic effect aguinst diverse apopiotic stimuli through blockage of mitochondrial release of cytochrome C and activation of caspaxe-3", Blood 91, 1700-1705.
  • Fang, G., Kim, C.N., Perkins, C.L., Ramadevi, N., Winton, E., Wittman, S. and Bhalla, K.N. (2000) "CGP57148B (STI-571)induces differentiation and apoptosis and sensitizes Ber-Ablpositive human leukemia cells to apoptosis due to antileukemic drugs", Blood 96, 2246-2253.
  • Vigneri, P. and Wang, J.Y. (2001) "Induction of apoptosis in chromic myelogenous leukemia cells through nuclear entrapment of BCRABL. tyrosine kinase", Nat, Med. 7, 228-234.
  • Delage, R., Soiffer, R.J., Dear, K. and Ritz, J. (1991) "Clinical significance of ber-abl gene rearrangement detected by polymerase chain reaction after allogeneic bone marrow transplantation in chromic myelogenous leukemia", Blood 78, 2759-2767.
  • Roth, M.S., Antin, J.H., Ash, R., Terry, V.H., Gotlieb, M., Silver, Philadelphia chromosome-positive cells detected by the polymerase chain reaction after allogeneic bone marrow transplati for chromic myelogeneous leukemia", Blood 79, 276-282.
  • Pichert, G., Alyea, E.P., Soiffer, R.J., Roy., D.C, and Ritz, J. (1994) "Persistence of myeloid progenitor cells expressing BCR-ABL mRNA after allogeneic bone marrow transplantation for chronic myelogenous leukemia", Blood 84, 2109-2114.
  • Pichert, G., Roy, D.C., Gonin, R., Alyea, E.P., Belanger, R., Gyger, M., Perreault, C., Bonny, Y., Lerra, I., Murray, C., Soiffer, R.J. and Ritz, J. (1995) "Distintct Patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemia" J. Clin. Oncol. 13, 1704-1713.
  • Alyea, E.P., Soiffer, R.J., Canning, C., Neuberg, D., Schlossman, R., Pickett, C., Collins, H., Wang, Y., Anderson, K.C. and Ritz, J.(1998) "Toxicity and efficacy of defined doses of CD4(+)donor lymphocytes for treatment of relapse after allogeneic bone marrow transplant", Blood 91, 3671-3680.
  • Preudhomme, C., Revillon, F., Merlat, A., Hornez, L., Roumier, C., Duflos-Grardel, N., Jouet, J.P., Cosson, A., Peyrat, J.P. and Fenaux, P. (1999) "Detection of BCR-ABL transcripts in chronic myeloid leukemia (CML) using a real time quantitative RT-PCR assay", Leukemia 13. 957-964.
  • Branford, S., Hughes, T.P. and Rudzki, Z. (1999) "Monitoring chronic myeloid leukaemia therapy by real-time quantitative PCR in blood is a reliable alternative to bone marrow cytogenetics", Br. J. Gaematol. 107, 587-599.
  • Kreuzer, K.A., Lass, U., Nagel, S., Ellerbrok, H., Pauli, Pauli, G., Pawlcyzyk-Peter, B., Siegert, W., Huhn, D. and Schmidt, C.A. (2000) "Applicability of an absolute quantitiative prodedure to monitor intra-individual ber/abl transcript Kinetics in clinical samples from chronic myelogenous leukemia Patients", Int. J. Cancer 86, 741-746.
  • Emig, M., Saussele, S., Wittor, H., Weisser, A., Reiter, A., Willer. A., Berger, U., Hehlmann, R., Cross, N.C. and Hochhaus, A. (1999) "Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR," Leukeemia 13, 1825-1832.
  • Eder, M., Battmer, K., Kafert, S., Stucki, A., Ganser, A. and Hertenstein, B. (1999) "Monitoring of BCR-ABL expression using real-time RT-PCR in CML after bone marrow or peropheral blood stem cell transplation", Lukemia 13, 1383-1389.
  • Hariharan, J.K. and Adams, J.M. (1987) "cDNA sequence for human ber, the gene that translocates to the abl oncogene in chronic myeloid leukaemia", Embo J. 6,115-119.
  • Meissner, R.V. Dias, P.M., Covas, D.T., Job, F., Leite, M. and Nardi, N.B. (1998) "A polymorphism in exon b2 of the major breakpoint cluster region (M-ber) identified in chronic myeloid leukaemia patients", Br. J. Haematol, 103, 224-226.
  • Cox, M.C., Maffei, L., Buffolino, S., Del Poeta, G., Venditti A., Cantonetti, M., Aronica, G., Aquilina, P., Masi, M. and Amadori, S.(1998) "A comparative analysis of FISH, RT-PCR, and cytogenetics for the diagnosis of ber-abl-positive leukemias" Am. J. Clim. Pathol 109, 24-31.
  • Duba, H.C., Hilbe, W., Mehringer, A., Erdel, M., Thaler, J. and Utermann, G.(2000) "Hypermataphase and interphase fluorescence in situ hybridisation for monitoring of remission status inPhiladelphia chromosome positive chronic myeloid leukaemia". Int. J. Oncol. 17, 1245-1249.
  • Radich, J.P., Gehly, G., Guoley, T., Bryant. E. Clift. R.A., Collins. S., Edmands. S.," Kirk, L, Lee. A., Kessler. P., et al, (1995)"Polymerase chain reaction detection of the BCR-ABL. fusion transcript after allogeneic marrow transplantation for chronic myeloid leukemia: results and implications in 346 patients", Blood 85, 2632-2658.
  • Olavania, K,. Kanfer, B., Szydlo. R., Kaeda, J., Rezvani, K., Cwynarski, K., Pocock, C., Dazzi, K, Craddock, C., Apperley. J.F., Cross. N.C, and Goldman, J.M. (2001) "Early detection of BCRABI transcripts by quantitative reverse transcriptase-polymerase chain reaction predicts outcome after allogencit stem cell transplantation for chronic myeloid leukemia", blood 97. 1560-1565.
  • Cross, N.P., Lin, F., Chase, A., Bungey. J., Hughes. T.P. and Goldman. J,M. (1993) "Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia patients after hone marrow transplantation". Blood 82. 1929-1936.
  • Lion, T., Izraeli, S, Henn. T., Gaiger. A., Mor. W. and Gadner, H. (1992) "Monitoring of residual disease in chronic myelogenous leukemia by quantitative polymerase chain reaction". Leukemia 6. 495-499.
  • Malinge, M.C., Mahon, F.X., Deltau. M.H., Daheron. L., Kilsis, A., Guilhot. F., Tanzer. J. and Grandchamp. B. (1992) "Quantitative determiation of the hybrid Ber-Abl RNA in patients with chronic myelogenons leukaemia under interferon therapy", Br. J. Haematol. 82, 701 - 707.
  • Martinelli, G., Tesloni, N., Amahile, M., Bonifazi. F., De Vivo, A., Farabegoli, P., Terragna, C. Montefuseo, V., Oltaviani, E., Russo. D., Baccarani, M. and Tura, S. (2000) "Quantification of BCR-ABL transcripts in CML patients in cylogenetic remission after interferon-n based therapy". Bone Marrow Transplant, 25. 729-736.
  • Messirik. E. van de Locht. A., Schallenberg. A., Linders, E., Sehaap. N., Geurts van Kessel. A. and De Witte, T. (1998) "Quantitation of minimal residual disease in Philadelphia chromosome positive chronic myeloid leukaemia patients using real-time quantitative RT-PCR", Br. J- Haematol. 102, 768-774.
  • Livak, K.J., Flood, S.J.A., Mannaro. J-. Gusti, W. and Deetz. K, (1995) "Oligonucleoitdes with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization", PCR Meth, Appl. 4, 357-362.
  • Heid, C.A., Stevens, J., Livak. K.J. and Williams. P.M. (1996) "Real-time quantitative PCR", Genome Res, 6, 986-994.
  • Preudhomme, C., Wattel, H., Lai. J.L. Henic, N., Meyer. L., Noel. M.P., COSSON, A., Jouet, J.P. and Fenaux. P. (1995) "Good predictive value of combined cytogenetic and molecular follow up in chronic myelogeneous leukemia after non T-cell depleted allogeneic hone marrow transplantation: a report on 38 consecutive cases", Leuk. Lymphomia 18, 265-271.
  • Hochhaus, A., Rester. A., Saubele, S., Reichert, A., Einig. M., Kaeda. J., Schulheis, B., Berger. U., Shepard, P.C.A., Allan, N.C., Hehlman, R. Goldman. J.M. and Cross. N.P. (2000) "Molecular heterogifneity in complete cytogenetic responders after inteiferun-a therapy for chronic myelogenous leukemia: low levels of minimal residual disease are associated with continuing remission". Blood 95, 62-66.
  • Seeger, K., Kreuzer. K.A. Lass, U., Taube, T., Buchwald. D., Eckert, C., Korner, G.,. Schmidt, C.A, and Henze, G. (2001) "Molecular quantification of response to therapy and remission status in TEL-AMLI-positive childhood ALL by real-time reverse transcription polymerase chain reaction". Cancer Res, 61. 2517-2522.
  • Perego, R.A., Costantini, M., Cornacchini, G., Gargantini, L, Bianchi, C., Pungolino. E., Rovida. E. and Morra. E (2000) "The possible influences of B2A2 and B3A2 BCR/ABL protein structure on thrombopoiesis in chronic myeloid leukaemia". Eur. J, Cancer 36, 1395-1401.
  • Stentoft, J., Pallisgaard, N., Kjeldsen. E., Holm, M.S., Meisen, J.L. and Hokland, P. (2001) "Kinetics of BCR-ABL fusion transcript levels in chronic myeloid leukemia patients treated with ST157I measured by quantitative real-time polymerase chain reaction". Ear. J. Haematol, 67, 302-308.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.